<DOC>
	<DOCNO>NCT01450943</DOCNO>
	<brief_summary>The primary objective study ass effectiveness cellular dermal replacement tissue vs. non-viable extracellular matrix ( ECM ) treatment non-healing diabetic foot ulcer . Our hypothesis device equal efficacy .</brief_summary>
	<brief_title>VA MERIT : A Comparative Efficacy Study : Treatment Non-Healing Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>( Answering NO exclude patient ) : 1 . An Institutional Review Board ( IRB ) Informed Consent Form sign date prior studyrelated activity . 2 . The area study ulcer debridement 1 cm2 25 cm2 Visit 3/Week 0 . 3 . Subjects 18 85 year age . 4 . Subject 's high AnkleBrachial Pressure Index ( ABPI ) / AnkleArm Index ( AAI ) great equal 0.80 low 1.4 ( high ABPI/AAI value three measurement within last 6 month shall apply ) .or toearm index equal high 0.6 . 5 . The patient one diabetic ulcer target foot one ulcer select study ( target ) ulcer . The target ulcer must least 4 cm nontarget ulcer Investigator 's opinion , unlikely coalesce another ulcer within 12 week randomization . 6 . Subject 's study ulcer full thickness extend bone , muscle , tendon . 7 . Subject 's study ulcer present least 4 week prior initial screening ( Visit 1 ) 6 week randomization ( Visit 3 ) . 8 . Subject diagnose Type 1 Type 2 diabetes HbA1c le 10 % . 9 . Study ulcer clinical feature infection ( 2 sign inflammation elevate bacterial load wound ) . 10 . For female subject childbearing age potential , subject negative pregnancy test lactate duration study . 11 . Subject understands requirement study willing comply study requirement . ( Answering YES exclude patient ) : 1 . The subject diagnose cancer undergo treatment immunosuppressive chemotherapeutic agent , radiotherapy systemic corticosteroid le 30 day enrollment . 2 . The subject diagnose HIV/AIDS . 3 . The subject diagnose bleeding disorder . 4 . The subject diagnose connective tissue disease . 5 . For female subject , subject pregnant lactating . 6 . The subject history illicit drug use within one year enrollment . 7 . In past year , subject experience episodes drink 5 alcoholic beverage less two hour and/or drink alcohol become problem interpersonal relationship , work , drive and/or behavior general . 8 . The subject active infect wound osteomyelitis ( confirm bone biopsy , MRI bone scan ) . 9 . Doppler exam within last 365 day demonstrate reflux great 0.5 second . 10 . The subject diagnose active Charcot describe Saunder 's classification system . 11 . The subject manifest sign poor nutritional status and/or albumin level &lt; 2.9 . 12 . The subject expose Dermagraft® and/or Oasis® last 60 day . 13 . The study ulcer size le 0.5 cm2 great 25 cm2 . 14 . The subject porcine allergy cow product allergy . 15 . The subject 's recent ( last 30 day ) chemistry test serum creatinine 2 time upper limit normal and/or LFT 's 3 time upper limit normal . 16 . Between Visit 1/Week 2 Visit 3/Week 0 ( randomization ) study ulcer decrease size 40 % , increase size 50 % .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Diabetic Foot Ulcer</keyword>
	<keyword>Chronic wound</keyword>
	<keyword>Chronic ulcer</keyword>
	<keyword>Oasis</keyword>
	<keyword>Dermagraft</keyword>
	<keyword>Adaptic</keyword>
</DOC>